跳至主要内容
临床试验/EUCTR2007-006595-11-HU
EUCTR2007-006595-11-HU进行中(未招募)不适用

Efficacy and Tolerability of Subcutaneous Progesterone (IBSA)versus Vaginal Progesterone Gel (Crinone®) for Luteal Phase Supportin Patients Undergoing In-Vitro Fertilization (IVF).

IBSA Institute Biochimique SA0 个研究点目标入组 672 人开始时间: 2008年7月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
672

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Age 18- 42 (upon starting COH);
  • - BMI <30 kg/m2;
  • - <3 prior ART cycles (IVF, ICSI and related procedures);
  • - Baseline (day 2-3 of cycling) FSH <15 IU/L and E2 <80 pg/mL;
  • - Normal uterine cavity as per recent hysterosalpingogram,
  • sonohystogram or hysteroscopic exam (i.e. no polyp or protruding
  • sub-mucosal fibroid);
  • - At least 3 retrieved oocytes;
  • - Patient has given written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Intramural uterine fibroids that distort the uterine cavity or polyps >1
  • - Stage III or IV endometriosis (endometriomas);
  • - Hydrosalpinx;
  • - History of past poor response to COH resulting in canceling ART;
  • - Use of thawed/donated oocytes;
  • - Use of thawed/donated embryos;
  • - Patients affected by pathologies associated with any contraindication
  • of being pregnant;
  • - Hypersensitivity to study medication;
  • - Uncontrolled adrenal or thyroid dysfunction;
  • - Undiagnosed vaginal bleeding;
  • - History of arterial disease;
  • - Patients with hepatic impairment;
  • - Neoplasias (current) or history of neoplasia that may be responsive to
  • progesterone;
  • - High grade cervical dysplasia;
  • - History of recurrent pregnancy loss defined as 3 or more spontaneous
  • miscarriages wherein pregnancy developed to a minimum of a
  • gestational sac on TVUS;
  • - Participation in a concurrent clinical trial or another trial within the
  • past 2 months;
  • - Use of concomitant medications that might interfere with the study
  • evaluation;
  • - Pre-implantation genetic diagnosis/screening.

研究者

发起方
IBSA Institute Biochimique SA

相似试验

进行中(未招募)
不适用
Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF).uteal phase support in patients undergoing Assisted Reproductive Technology (IVF).MedDRA version: 14.1Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disorders
EUCTR2007-006595-11-ITIBSA672
进行中(未招募)
1 期
Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF).Patients undergoing in-Vitro Fertilization (IVF)MedDRA version: 9.1 Level: LLT Classification code 10021572 Term: In vitro fertilization
EUCTR2007-006595-11-GBIBSA Institut Biochimique SA
进行中(未招募)
不适用
Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone?) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF).Patient undergoing in-Vitro Fertilization (IVF)MedDRA version: 9.1Level: LLTClassification code 10021572Term: In vitro fertilization
EUCTR2007-006595-11-DEIBSA Institut Biochimique SA672
招募中
Unknown
Evaluation of Efficacy and Safety of subcutaneous Remsima injection in Subjetcs with Active Ankylosing SpondylitisDiseases of the musculoskeletal system and connective tissue
KCT0008747CHONNAM NATIONAL UNIVERSITY BITGOEUL HOSPITA60
尚未招募
2 期
ESAR-814 StudyRheumatoid arthritis with moderate activityArthritis, RheumatoidArthritisJoint DiseasesRheumatic DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases
RPCEC00000230Center for Genetic Engineering and Biotechnology (CIGB), in Havana196